CorVel Announces Revenues and Earnings
CorVel Corporation (NASDAQ: CRVL) reported strong financial results for Q1 FY2026. The company achieved revenue of $235 million, an 11% increase from the previous year, while earnings per share grew 24% to $0.52. Gross profit rose 18% to $56.8 million, maintaining a 24% gross margin.
The company ended the quarter with a robust cash position of $202 million and no debt, while executing $9.6 million in share repurchases. Additionally, CorVel completed a strategic acquisition of assets and talent from a private technology firm to enhance its CERIS group health division capabilities, expected to be accretive to growth in the medium term.
CorVel Corporation (NASDAQ: CRVL) ha riportato risultati finanziari solidi per il primo trimestre dell'anno fiscale 2026. L'azienda ha raggiunto un fatturato di 235 milioni di dollari, con un aumento dell'11% rispetto all'anno precedente, mentre gli utili per azione sono cresciuti del 24% attestandosi a 0,52 dollari. Il profitto lordo è salito del 18% a 56,8 milioni di dollari, mantenendo un margine lordo del 24%.
La società ha chiuso il trimestre con una solida posizione di cassa di 202 milioni di dollari e senza debiti, effettuando inoltre riacquisti di azioni per 9,6 milioni di dollari. Inoltre, CorVel ha completato un'acquisizione strategica di asset e talenti da una società privata di tecnologia per potenziare le capacità della sua divisione sanitaria CERIS, operazione che si prevede contribuirà alla crescita nel medio termine.
CorVel Corporation (NASDAQ: CRVL) reportó sólidos resultados financieros para el primer trimestre del año fiscal 2026. La compañía alcanzó unos ingresos de 235 millones de dólares, un aumento del 11% respecto al año anterior, mientras que las ganancias por acción crecieron un 24% hasta 0,52 dólares. La ganancia bruta aumentó un 18% hasta 56,8 millones de dólares, manteniendo un margen bruto del 24%.
La empresa finalizó el trimestre con una fuerte posición de efectivo de 202 millones de dólares y sin deuda, ejecutando además recompras de acciones por 9,6 millones de dólares. Adicionalmente, CorVel completó una adquisición estratégica de activos y talento de una empresa tecnológica privada para mejorar las capacidades de su división de salud grupal CERIS, que se espera contribuya al crecimiento a mediano plazo.
CorVel Corporation (NASDAQ: CRVL)는 2026 회계연도 1분기 강력한 재무 실적을 보고했습니다. 회사는 2억 3,500만 달러의 매출을 기록하며 전년 대비 11% 증가했고, 주당순이익은 24% 증가한 0.52달러를 달성했습니다. 총이익은 18% 증가한 5,680만 달러로, 24%의 총이익률을 유지했습니다.
회사는 분기 말에 2억 200만 달러의 견고한 현금 보유고와 무부채 상태를 유지했으며, 9.6백만 달러 규모의 자사주 매입을 실행했습니다. 또한 CorVel은 중기 성장에 기여할 것으로 예상되는 CERIS 그룹 건강 부문의 역량 강화를 위해 민간 기술 회사로부터 자산과 인재를 전략적으로 인수 완료했습니다.
CorVel Corporation (NASDAQ : CRVL) a publié de solides résultats financiers pour le premier trimestre de l'exercice 2026. La société a réalisé un chiffre d'affaires de 235 millions de dollars, soit une augmentation de 11 % par rapport à l'année précédente, tandis que le bénéfice par action a progressé de 24 % pour atteindre 0,52 dollar. Le bénéfice brut a augmenté de 18 % pour atteindre 56,8 millions de dollars, maintenant une marge brute de 24 %.
L'entreprise a terminé le trimestre avec une position de trésorerie robuste de 202 millions de dollars et sans dette, tout en réalisant des rachats d'actions pour 9,6 millions de dollars. De plus, CorVel a finalisé une acquisition stratégique d'actifs et de talents auprès d'une entreprise technologique privée afin de renforcer les capacités de sa division santé de groupe CERIS, ce qui devrait contribuer à la croissance à moyen terme.
CorVel Corporation (NASDAQ: CRVL) meldete starke Finanzergebnisse für das erste Quartal des Geschäftsjahres 2026. Das Unternehmen erzielte einen Umsatz von 235 Millionen US-Dollar, was einer Steigerung von 11 % gegenüber dem Vorjahr entspricht, während der Gewinn je Aktie um 24 % auf 0,52 US-Dollar stieg. Der Bruttogewinn stieg um 18 % auf 56,8 Millionen US-Dollar und hielt eine Bruttomarge von 24 %.
Das Unternehmen beendete das Quartal mit einer soliden Cash-Position von 202 Millionen US-Dollar und ohne Schulden, wobei Aktienrückkäufe im Wert von 9,6 Millionen US-Dollar durchgeführt wurden. Zusätzlich schloss CorVel eine strategische Übernahme von Vermögenswerten und Talenten eines privaten Technologieunternehmens ab, um die Fähigkeiten seiner CERIS-Gruppengesundheitsdivision zu stärken, was mittelfristig wachstumsfördernd erwartet wird.
- Revenue increased 11% year-over-year to $235 million
- Earnings per share grew 24% to $0.52
- Gross profit improved 18% to $56.8 million with 24% margins
- Strong cash position of $202 million with zero debt
- Strategic technology acquisition to enhance CERIS division capabilities
- Slight decrease in weighted shares from 51,939,000 to 51,912,000
- General and administrative expenses increased 6.7% to $21.5 million
Insights
CorVel delivered strong Q1 FY2026 results with double-digit growth across revenue, profit, and EPS, while expanding margins and making strategic acquisitions.
CorVel Corporation has posted impressive first quarter results for fiscal year 2026, with substantial growth across key financial metrics. Revenue increased
The bottom line showed even stronger improvement, with diluted earnings per share climbing
CorVel's balance sheet remains robust with
The acquisition of assets and talent from a private technology firm aligns with CorVel's innovation strategy, particularly in strengthening their CERIS group health division. Management expects this acquisition to accelerate growth in the medium term while enhancing their technological capabilities. The company's mention of R&D investments in agentic AI suggests a forward-looking approach to maintaining competitive advantages in their industry.
This quarter demonstrates CorVel's consistent execution capability and focus on balancing current performance with strategic long-term investments in technology and innovation.
FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were
First Quarter Fiscal Year 2026 Highlights
- Revenue increased
11% to$235 million , compared to first quarter of fiscal year 2025. - Gross profit increased
18% to$56.8 million , at24% gross margin, compared to first quarter of fiscal year 2025 gross profit of$48.2 million . - Diluted earnings per share increased
24% to$0.52 , compared to first quarter of fiscal year 2025 diluted earnings per share of$0.42 . - Exited the quarter with
$202 million of cash, cash equivalents, and no borrowings. - The Company repurchased
$9.6 million of common stock during the quarter.
The results achieved in the quarter were driven by disciplined execution and a clear focus on long-term strategy. CorVel’s teams continue to advance innovation initiatives, including targeted R&D in agentic AI, strengthen operational capabilities, enhance customer outcomes, and deliver sustainable value for shareholders.
As part of CorVel’s ongoing commitment to innovation and long-term growth, the Company has completed the acquisition of assets and key talent from a privately held technology firm. The acquired assets include proprietary tools and intellectual property that are expected to enhance the capabilities of the CERIS group health division. This acquisition provides additional strength to foundational technologies and aligns with the strategic vision of delivering advanced, scalable solutions to CERIS partners. The integration of these assets will enhance innovation, reduce time-to-market, and increase the value provided in many areas. The transaction was completed in July and the Company expects the transaction to be accretive to growth over the medium term.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, improved productivity resulting from automation and augmentation across enterprise business systems. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement results of operations and financial condition is greater than our initial assessment. The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2025, and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2024, September 30, 2024, and December 31, 2024. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.
| CorVel Corporation Quarterly Results – Income Statement Quarters Ended June 30, 2025 (unaudited) and June 30, 2024 (unaudited) | ||||||||
| Quarter Ended | June 30, 2025 | June 30, 2024 | ||||||
| Revenues | $ | 234,711,000 | $ | 211,722,000 | ||||
| Cost of revenues | 177,950,000 | 163,567,000 | ||||||
| Gross profit | 56,761,000 | 48,155,000 | ||||||
| General and administrative | 21,478,000 | 20,120,000 | ||||||
| Income from operations | 35,283,000 | 28,035,000 | ||||||
| Income tax provision | 8,048,000 | 6,458,000 | ||||||
| Net income | $ | 27,235,000 | $ | 21,577,000 | ||||
| Earnings Per Share: | ||||||||
| Basic | $ | 0.53 | $ | 0.42 | ||||
| Diluted | $ | 0.52 | $ | 0.42 | ||||
| Weighted Shares | ||||||||
| Basic | 51,352,000 | 51,366,000 | ||||||
| Diluted | 51,912,000 | 51,939,000 | ||||||
| CorVel Corporation Quarterly Results – Condensed Balance Sheet June 30, 2025 (unaudited) and March 31, 2025 | ||||||||
| June 30, 2025 | March 31, 2025 | |||||||
| Cash | $ | 202,025,000 | $ | 170,584,000 | ||||
| Customer deposits | 108,138,000 | 101,472,000 | ||||||
| Accounts receivable, net | 101,975,000 | 104,126,000 | ||||||
| Prepaid taxes and expenses | 9,486,000 | 10,507,000 | ||||||
| Property, net | 108,440,000 | 92,052,000 | ||||||
| Goodwill and other assets | 46,779,000 | 46,410,000 | ||||||
| Right-of-use asset, net | 20,605,000 | 20,825,000 | ||||||
| Total | $ | 597,448,000 | $ | 545,976,000 | ||||
| Accounts and taxes payable | $ | 30,689,000 | $ | 16,792,000 | ||||
| Accrued liabilities | 204,532,000 | 187,244,000 | ||||||
| Long-term lease liabilities | 19,695,000 | 19,953,000 | ||||||
| Paid-in capital | 253,339,000 | 250,412,000 | ||||||
| Treasury stock | (841,127,000 | ) | (831,510,000 | ) | ||||
| Retained earnings | 930,320,000 | 903,085,000 | ||||||
| Total | $ | 597,448,000 | $ | 545,976,000 | ||||
Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com
FAQ
What were CorVel's (CRVL) Q1 2026 earnings per share?
How much revenue did CorVel (CRVL) generate in Q1 2026?
What is CorVel's (CRVL) current cash position?
What acquisition did CorVel (CRVL) complete in 2025?
How much stock did CorVel (CRVL) repurchase in Q1 2026?
